Antibiotic treatment inhibits paclitaxel chemotherapy-induced activity deficits in female mice

PLoS One. 2023 May 11;18(5):e0284365. doi: 10.1371/journal.pone.0284365. eCollection 2023.

Abstract

Chemotherapy, a mainstay in the treatment of cancer, is associated with severe and debilitating side effects. Side effects can be physical (e.g., gastrointestinal distress, anemia, and hair loss) or mental (e.g., fatigue, cognitive dysfunction). Chemotherapy is known to alter the gut microbiota; thus, communication through the gut-brain axis may influence behavioral side effects. Here, we used a clinically-relevant paclitaxel chemotherapy regimen in combination with antibiotics to test the hypothesis that gut microbes contribute to chemotherapy-associated fatigue-like behaviors in female mice. Data presented suggest that chemotherapy-altered gut microbes contribute to fatigue-like behaviors in mice by disrupting energy homeostasis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Anti-Bacterial Agents / adverse effects
  • Antineoplastic Agents* / therapeutic use
  • Cognitive Dysfunction* / drug therapy
  • Drug-Related Side Effects and Adverse Reactions* / drug therapy
  • Fatigue / chemically induced
  • Female
  • Mice
  • Paclitaxel / adverse effects

Substances

  • Paclitaxel
  • Anti-Bacterial Agents
  • Antineoplastic Agents

Associated data

  • figshare/10.6084/m9.figshare.20418951

Grants and funding

This work was supported by National Institute of Health, National Cancer Institute grant CA216290 and an associated personnel supplement -04S2 (L.P., C.G. [trainee]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.